Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Re: Sorry, but I just had to laugh at 2 things today-bean

I would hope that the BoD would use our posts to their advantage. If Charlie Hoge (attorney) could demonstrate to the judge that Leckrone has damaged and continues to damage all PTSC shareholders, perhaps it might help all of us.

If money ever was to start flowing in again from license agreements, I still believe that all of our directors should be replaced and in doing so, it may just give this company a fresh start with new ideas from new people.

Don't forget that in Leckrone's declaration, he states that he places a value of around $1 billion on the MMP. I glossed over it when reading, so I'm not sure if that figure includes the licenses already signed or if it speaks to future revenue only.....either way, it's not that much after expenses and the split. I would rather the BoD pay the money to all of us in dividends. I do not trust them to grow the company because of their track record.

Share
New Message
Please login to post a reply